Lockout/Tagout solutions supplier in Italy: how to choose

What a LOTO "solution" really includes

The term "LOTO solution" is used loosely. A device reseller uses it to mean an assortment of padlocks, hasps, tags and blind flanges. A safety consultant uses it to mean procedures and training. In a real production site, and even more so in a pharmaceutical one, a complete solution must hold together five components:

Isolation and signalling devices. Padlocks with unique keys, multiple hasps for team operations, blocking devices for valves and switches, tagout tags, and — where UNI EN 17975:2025 requires reinforced isolation — the additional physical separation (blind flange, removal of a section of piping, mechanical disconnection).

Written operating procedures. The SOPs describing step by step how a specific machine or line is isolated, who authorizes, who applies, who verifies the Try-Out, who removes. Without procedures, devices are just hardware.

Risk assessment support. The analysis that, for each maintenance activity, defines which isolation process to apply (RI by default, otherwise justified) according to the principles of UNI EN ISO 12100.

Structured training. Distinct and recorded programs for the safety manager, maintenance staff, supervisors and line operators, with periodic verification. The 17975 explicitly closes the era of untraced "on-the-job" training.

Management system, increasingly digital. A register of operations that is reliable in audit: traced applications and removals, managed parent/child sequences, a non-disableable audit trail. It is the component that distinguishes a hardware supplier from a process partner.

Whoever covers only the first point sells devices. Whoever holds together all five points — or knows how to integrate with those who cover the others — is a process partner. The difference becomes decisive when an inspector arrives.

Device vendor or process partner

It is the most important and the most overlooked distinction. A device vendor optimizes for the product: breadth of catalogue, price, stock availability. It is a legitimate and often sufficient choice for a mechanical workshop with few isolation points and rare operations.

A process partner optimizes for the outcome: that the isolation is correct, documented and defensible in audit. It brings regulatory competence, helps write the procedures, trains the personnel and provides the traceability tool suited to the complexity of the site. It costs more to engage, but it reduces the hidden cost — the one that emerges when a production deviation traces back to the maintenance → LOTO → record chain and the record does not hold up.

The choice between the two is not ideological: it depends on the complexity of the plant, the frequency of operations and the regulatory regime. In a GMP context, the process partner is almost always the correct choice, for the reason explained in the next section.

Why the GMP context changes the criteria

In a pharmaceutical site, the LOTO register is not only a safety document: it is a quality record subject to data integrity principles. This shifts the criteria for evaluating the supplier onto a plane that a device reseller generally does not cover. The criteria that matter:

Competence in a regulated environment. Does the supplier understand what a change control is, what an FDA or EMA inspector asks, what it means to qualify a system? Or do they only know safety hardware? It is the discriminating question.

Alignment with UNI EN 17975:2025. The European standard requires the formalization of the four isolation processes, the Try-Out phase, the management of parent/child relationships and substantial traceability. A serious supplier knows the standard and can translate it into consistent devices, procedures and tools. It is worth reading the guide to UNI EN 17975:2025 to understand what to ask.

ALCOA+ and Annex 11 traceability. If the digital component of the solution manages quality records, it must meet the requirements for computerized systems: a non-disableable audit trail, unique operator identification, compliance with the EU GMP Annex 11 and, where the site exports to the US, with 21 CFR Part 11. The topic is explored in the article on paper or digital LOTO in a GMP audit.

Integration with change control. Can the solution link the LOTO performed to the authorization that made it possible, to the work order, to the closure report? The linkage between systems is what makes the chain reconstructable in audit without effort.

Qualifiability. If there is software, does the supplier provide the documentation to support qualification according to GAMP5 (URS, FS, DS, IQ, OQ, PQ proportionate to the risk)? Software that cannot be qualified, in GMP, is not usable.

How to evaluate a supplier: concrete questions

Before signing, a few questions quickly reveal the difference between a catalogue and a partner:

1. Do you know UNI EN 17975:2025 and can you tell me which isolation process applies to my activity X? If the answer is vague, it is a reseller.
2. Does the digital component have a non-disableable audit trail compliant with Annex 11? If they do not know what that means, it is not suited to GMP.
3. Do you provide the documentation for the GAMP5 qualification of the software?
4. Do you help write the procedures or do you only sell the devices?
5. How do you manage parent/child sequences on a plant with dozens of isolation points?
6. Do you have real experience in regulated pharmaceutical sites?

The answers clearly separate those who sell hardware from those who oversee the process.

When a device supplier is enough

It is honest to say it: not every site needs a process partner. If the plant has few isolation points, operations are rare, there is no GMP regime and the team is small and stable, a good device supplier with internally written procedures and a well-kept paper register is a legitimate and proportionate choice. Over-dimensioning is a waste just as under-dimensioning is a risk. The criterion, again, is the real complexity of the site, not the ambition of the specification.

The Eurosystem experience

Eurosystem has operated since 1990 in regulated pharmaceutical sites, where it manages over 11,000 critical instruments through the Dimacs system and where the GMP audit is the norm, not the exception. From this experience SmartLOTO was born: not a padlock catalogue, but an intelligent LOTO cabinet with selective padlock release and a digital audit trail, designed around the requirements of UNI EN 17975:2025, supported by help with drafting the procedures and integrating with the site. We propose it as a combination of hardware, software and process — not as a universal solution. Where a device supplier and a disciplined paper system are enough, we say so openly. You can discover SmartLOTO to understand how this combination translates into practice.